Next Biomedical Co.,Ltd. (KOSDAQ:389650)

South Korea flag South Korea · Delayed Price · Currency is KRW
48,700
+3,600 (7.98%)
At close: Jul 18, 2025, 3:30 PM KST
80.37%
Market Cap366.52B
Revenue (ttm)10.95B
Net Income (ttm)2.79B
Shares Out8.13M
EPS (ttm)-255.76
PE Ratio131.19
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume195,285
Average Volume66,563
Open45,000
Previous Close45,100
Day's Range44,450 - 49,000
52-Week Range21,400 - 60,800
Betan/a
RSI54.84
Earnings Daten/a

About Next Biomedical

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 389650
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.